Recently the new Dutch e-learning of the NFU BROK® course was officially launched. You can register for this e-learning course via nfu-ebrok.nl (currently only available in Dutch, the English translation is expected to be available on January 1, 2020). The Basic course on Regulations and Organisation for clinical investigators (BROK®) addresses legislation and regulations that apply to research and is mandatory for all researchers who are involved in human-based research.
For whom is this new e-learning?
The new e-learning is not only for researchers who want to obtain their BROK® certificate, but also for researchers who already have a BROK® certificate and want to keep their certification (re-certification). Check the online BROK© register to see the expiration date of your certificate.
Subscribe to the e-learning if you fall into one of the categories below:
- You want to obtain a BROK®-certificate or your current certificate has expired. Subscribe to the e-learning and follow the complete BROK®-course. Note, that if your current certificate has expired, you will be eligible for a reduced rate.
- You currently have a valid BROK®-certificate that is about to expire. Subscribe to the e-learning before your certificate is about to expire and follow a mandatory re-registration module which renews your certification and provides access to all course modules.
- You still have a valid certificate? Even then you can subscribe to the e-learning. The new e-learning offers the possibility to purchase a subscription (directly) after obtaining your certificate. You will then receive reminders when there are changes in legislation and regulations so that you stay up-to-date. If you have reviewed these changes in time, your certificate will be automatically extended: from now on, re-certification will become continuous learning.
Related news items
Frank Walboomers 25-years work anniversary at Radboudumc17 September 2020
Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.read more
Centuries-old medicine reduces the risk of new cardiovascular disease in heart patients17 September 2020
Colchicine, an anti-inflammatory drug that has been used for gout for centuries, has been shown to prevent cardiovascular disease in patients who have had a heart attack or are suffering from narrowed coronary arteries. Results of the study are published in the New England Journal of Medicine.read more
Radboudumc does large-scale research on systemic sclerosis10 September 2020
In rare diseases, such as systemic sclerosis, it’s often difficult to conduct large-scale research. Rheumatologist Madelon Vonk has managed to follow enough patients with systemic sclerosis for years. The results of her research have been published in BMJ Annal of the Rheumatic Diseases.read more
Transfer of new anti-hepatitis C drugs across the human placenta9 September 2020
In a recent publication in American Journal of Obstetrics and Gynecology, researchers from the Departments of Pharmacology and Toxicology, Pharmacy, Obstetrics and Gynecology, Gastroenterology and Hepatology, investigated the placental passage of two such drugs for the first time.read more